Note: Ingredients listed on restricted chemical lists
EC/CAS
265-157-1/64742-54-7
Name of the chemical
Distillates (petroleum), hydrotreated heavy paraffinic
Concentration
35 - 50
EC/CAS
276-738-4/72623-87-1
Name of the chemical
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based
Concentration
≥15
General Information
Version
2.6
Revision date
2022-11-30
Product name
76390 - Gear Oil TDL Synth 75W-90
1.2.1 Relevant identified uses
Professional use,Consumer use Industrial/Professional use spec Industrial
Emergency telephone
+31 (0)78 6527652, +44 20 7188 7188
Icons in SDS
Company Information
company name
Transnational Blenders B.V.
e-mail address of the competent person responsible for the Safety Data Sheet
technical@tnb.nl
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Contains
Reaction products of 4-methyl-2-pentanol and diphosphorus pentasulfide, propoxylated, esterified with diphosphorus pentaoxide, and salted by amines, C12-14- tert-alkyl
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P261 - Avoid breathing dust, fume, mist, vapours. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %